Search
Search Results
##search.searchResults.foundPlural##
-
EPIDEMIOLOGY OF IMPORTED MALARIA IN THE MEDITERRANEAN REGION
3238PDF: 1104HTML: 16477 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1508PDF: 929HTML: 1965 -
High level of HBV DNA virus in the breast milk seems not to contraindicate breastfeeding
2293PDF: 852HTML: 967Untitled: 287 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10897PDF: 6530HTML: 21954 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
2019PDF: 1155HTML: 1929Lung computed tomography CT scan image: 222 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3371PDF: 1518HTML: 5969Fig1-Ag-Pil: 263Ag-Pil Fig.2: 261 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1262PDF: 568HTML: 1710Figures: 191Fifures Sanz: 200tables Sanz: 205Untitled: 196 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1893PDF: 767HTML: 473 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1972PDF: 762HTML: 248 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2465PDF: 1037HTML: 1664Fig 1: 214Tab I: 240Cover Letter: 238 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1477PDF: 792HTML: 549 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1742PDF: 1043HTML: 1892Untitled: 222Untitled: 204 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1449PDF: 960HTML: 1675Figure 1: 197 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2974PDF: 1151HTML: 481Preferred Reviewers: 235 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1593PDF: 935HTML: 386 -
Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19
3281PDF: 1916HTML: 992 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1702PDF: 1352HTML: 174







